- Report
- July 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,728GBP
€3541EUR$3,939USD£3,031GBP
- Report
- June 2026
- 183 Pages
Global
From €3187EUR$3,545USD£2,728GBP
€3541EUR$3,939USD£3,031GBP
- Report
- June 2026
- 190 Pages
Global
From €3187EUR$3,545USD£2,728GBP
€3541EUR$3,939USD£3,031GBP
- Report
- April 2026
- 200 Pages
Global
From €2688EUR$2,990USD£2,301GBP
- Report
- June 2026
- 200 Pages
Global
From €2688EUR$2,990USD£2,301GBP
- Report
- November 2025
- 90 Pages
Global
From €4405EUR$4,900USD£3,770GBP
- Report
- April 2026
- 135 Pages
Global
From €2696EUR$2,999USD£2,308GBP
€3595EUR$3,999USD£3,077GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,455GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,455GBP
- Report
- July 2026
- 480 Pages
Global
From €5259EUR$5,850USD£4,501GBP
- Report
- July 2026
- 475 Pages
Global
From €5259EUR$5,850USD£4,501GBP
- Report
- July 2026
- 323 Pages
Global
From €5259EUR$5,850USD£4,501GBP
- Report
- July 2026
- 299 Pages
Global
From €5259EUR$5,850USD£4,501GBP
- Report
- July 2026
- 188 Pages
Global
From €3187EUR$3,545USD£2,728GBP
€3541EUR$3,939USD£3,031GBP
- Report
- August 2025
- 186 Pages
Global
From €3187EUR$3,545USD£2,728GBP
€3541EUR$3,939USD£3,031GBP
- Report
- May 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,463GBP
- Report
- January 2026
- 180 Pages
Global
From €4045EUR$4,500USD£3,463GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,455GBP

The Respiratory Infection market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the respiratory system. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, and other respiratory infections. Treatment options for these conditions include medications, lifestyle changes, and in some cases, surgery.
The Respiratory Infection market is a rapidly growing field, with new treatments and technologies being developed to improve patient outcomes. Companies in this market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples of companies in this market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Show Less Read more